Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The porphyrias: advances in diagnosis and treatment

Manisha Balwani, Robert J. Desnick

Blood (2012) 120 (23): 4496–4504.

https://doi.org/10.1182/blood-2012-05-423186

Published: 2012

Journal Articles

Congenital Erythropoietic Porphyria Due to Co-Inheritance of GATA1 and UROS Gene Mutations

Zeynep Karakas, MD, Chiara Refaldi, Valentina Brancaleoni, Ismail Kurt, MD, Elena Di Pierro, PhD, Maria Domenica Cappellini, MD

Blood (2010) 116 (21): 3208.

https://doi.org/10.1182/blood.V116.21.3208.3208

Published: 2010

Journal Articles

Cellular Distribution of Porphyrins In Porphyria Cutanea Tarda

John D Phillips, PhD, Hector A Bergonia, James P. Kushner, MD

Blood (2010) 116 (21): 165.

https://doi.org/10.1182/blood.V116.21.165.165

Published: 2010

Journal Articles

Identification and Characterization of Feline Acute Intermittent Porphyria: The First Naturally-Occurring Animal Model.

Sonia Clavero, PhD, David F Bishop, PhD, Mark E Haskins, VMD, PhD, Raili Kauppinen, MD, PhD, Urs Giger, PD, DMV, Robert J Desnick, MD

Blood (2009) 114 (22): 3014.

https://doi.org/10.1182/blood.V114.22.3014.3014

Published: 2009

Journal Articles

The Uroporphomethene Inhibitor Causitive for Porphyria Cutanea Tarda (PCT) Is Generated by Oxidation of Hydroxymethylbilane (HMB)

John D Phillips, PhD, Hector A Bergonia, Christopher A Reilly, Michael R Franklin, James P Kushner

Blood (2008) 112 (11): 3454.

https://doi.org/10.1182/blood.V112.11.3454.3454

Published: 2008

Journal Articles

Congenital erythropoietic porphyria due to a mutation in GATA1 : the first trans -acting mutation causative for a human porphyria

John D. Phillips, David P. Steensma, Michael A. Pulsipher, Gerald J. Spangrude, James P. Kushner

Blood (2006) 109 (6): 2618–2621.

https://doi.org/10.1182/blood-2006-06-022848

Published: 2006

Journal Articles

An Inhibitor of Uroporphyrinogen Decarboxylase (URO-D) Causes Porphyria Cutanea Tarda (PCT).

James P. Kushner, MD, Michael R. Franklin, PhD, Christopher P. Reilly, PhD, Hector A. Bergonia, MS, John D. Phillips, PhD

Blood (2006) 108 (11): 270.

https://doi.org/10.1182/blood.V108.11.270.270

Published: 2006

Journal Articles

Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.

John D. Phillips, PhD, David P. Steensma, MD, Gerald J. Spangrude, PhD, James P. Kushner, MD

Blood (2005) 106 (11): 515.

https://doi.org/10.1182/blood.V106.11.515.515

Published: 2005

NARROW

The porphyrias: advances in diagnosis and treatment

Congenital Erythropoietic Porphyria Due to Co-Inheritance of GATA1 and UROS Gene Mutations

Cellular Distribution of Porphyrins In Porphyria Cutanea Tarda

Identification and Characterization of Feline Acute Intermittent Porphyria: The First Naturally-Occurring Animal Model.

The Uroporphomethene Inhibitor Causitive for Porphyria Cutanea Tarda (PCT) Is Generated by Oxidation of Hydroxymethylbilane (HMB)

Congenital erythropoietic porphyria due to a mutation in GATA1 : the first trans -acting mutation causative for a human porphyria

An Inhibitor of Uroporphyrinogen Decarboxylase (URO-D) Causes Porphyria Cutanea Tarda (PCT).

Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only